Research and Development

Spanning one third of the globe's circumference and home to more than half of the world's population, the Asia Pacific …

Bristol-Myers Squibb andAstraZeneca's type II diabetes treatment Onglyza is among the brands to have received positive opinions from the Committee …

Pfizer has halted a phase III trial for its oncology hope Sutent, after it failed to show significant improvement in …

Roche is to give up its ABPI membership in a surprise move that could undermine the UK’s system of industry …

 A lawyer once told me that the law has nothing to do with morals. This wasn’t really a surprise, but …

Bayer Schering Pharma has signed a deal with Celera to give it access to five cancer-related targets for therapeutic development …

PPD has cancelled plans to occupy a facility at the North Carolina Research Campus in the US, blaming construction delays …

Pharmafocus presents a round-up of developments in the contract research sector, including a successful IPO by Medidata, Pierrel's imminent acquisition …

Japan has approved its first biosimilar medicine – the recombinant human growth hormone somatropin from Novartis' generic arm Sandoz. The …

Merck & Co is participating in two projects designed to help improve healthcare in Africa. The pharma giant will join …

GlaxoSmithKline and Oxford-based Chroma Therapeutics are linking up to identify small molecule therapeutics in a bid to combat conditions like …

Astellas has struck a deal with Californian company NeurogesX to market in Europe a treatment for pain linked to peripheral …